Clearside Biomedical (CLSD) said Monday it has filed for Chapter 11 Bankruptcy in the US Bankruptcy Court for the District of Delaware.
Clearside also said it plans to seek authorization for an auction and sale process under Section 363 of the US Bankruptcy Code, and has filed motions with the court seeking the continuation of normal operations during the process.
Clearside shares were down nearly 66% in early trading.
Price: 0.92, Change: -1.77, Percent Change: -65.80
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments